Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Rang in aandelen #28327
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Aandeelprijs
$1.11
Marktkapitalisatie
$27.17M
Verandering (1 dag)
0.19%
Verandering (1 jaar)
58.22%
Land
KR
Handel Dong Sung Bio Pharm.Co.,Ltd. (002210)

Categorie

Omzet van Dong Sung Bio Pharm.Co.,Ltd. (002210)
Omzet in Mar 2026 TTM: $55.28M
Volgens de laatste financiële rapporten van Dong Sung Bio Pharm.Co.,Ltd. bedraagt de huidige omzet van het bedrijf (TTM) $55.28M. In 2023 behaalde het bedrijf een omzet van $68.44M een daling ten opzichte van de omzet in het jaar 2022, die $73.96M bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van Dong Sung Bio Pharm.Co.,Ltd. van 2007 tot 2026
Omzet aan het einde van elk jaar
Jaar Omzet Wijzigen
2026 (TTM) $55.28M -8.11%
2024 $60.16M -12.09%
2023 $68.44M -7.47%
2022 $73.96M 4.17%
2021 $71.00M -12.21%
2020 $80.87M 7.92%
2019 $74.94M -9.21%
2018 $82.54M 6.78%
2017 $77.30M 16.92%
2016 $66.12M 4.07%
2015 $63.53M -4.97%
2014 $66.85M -6.37%
2013 $71.41M -10.13%
2012 $79.45M 17.40%
2011 $67.68M 5.52%
2010 $64.14M 8.31%
2009 $59.22M 22.81%
2008 $48.22M -25.17%
2007 $64.44M 0.00%
Omzet van vergelijkbare bedrijven of concurrenten